EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Non‐ albicans Candida in Vulvovaginal Candidiasis: Antifungal Resistance and Expression of ERG11 , CDR1 , CDR2 , and MDR1 Genes

Fatemeh Zahra Ranjbar Golafshani iD, Firoozeh Kermani iD, Soheila Abbaszadeh Godarzi iD, Saeid Mahdavi Omran iD

MicrobiologyOpen · 2025-12 · 14 (6)

DOI: 10.1002/mbo3.70123 ↗

Kurz gefasst

Fachartikel in der Zeitschrift MicrobiologyOpen, online erschienen am 30.11.2025. Verfasst von Fatemeh Zahra Ranjbar Golafshani und 3 weiteren Autor:innen. Beteiligte Einrichtung: Parasitology and Medical Mycology Department, Faculty of Medicine, Babol University of Medical Sciences, Babol, Iran. Hauptthemen laut MEDLINE: Candidiasis, Vulvovaginal, Antifungal Agents, Drug Resistance, Fungal, Fungal Proteins. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 53 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: This paper is supported by the financial grant associated with the M.Sc. dissertation of Fatemeh Zahra Ranjbar Golafshani at Babol University of Medical Scienc….

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The rise in azole resistance among Nakaseomyces glabratus and Pichia kudriavzevii in recurrent vulvovaginal candidiasis presents a growing public health challenge. This study investigated the expression of antifungal resistance‐related genes ( ERG11 , CDR1 , CDR2 , and MDR1 ) in clinical resistant (CR) and clinical and laboratory resistant (CLR) strains of these yeasts. Cervicovaginal samples from patients with recurrent infections were collected, microscopically examined, and cultured. Yeast species were identified phenotypically and genotypically, followed by drug sensitivity testing. Total RNA was extracted, reverse transcribed to complementary DNA, and real‐time polymerase chain reaction was used to quantify target gene expression, comparing results to drug‐sensitive controls. Non‐ Candida albicans species constituted 29% (45 cases) of the isolates, with N. glabratus (68%) and P. kudriavzevii (17%) being the dominant species. Other species included Candida parapsilosis, Meyerozyma guilliermondii , Candida orthopsilosis , Saccharomyces cerevisiae , and Rhodotorula mucilaginosa . Coinfections with P. kudriavzevii/C. albicans and N. glabratus/C. albicans were also observed. Ketoconazole, itraconazole, and 5‐flucytosine demonstrated the best antifungal activity against most species. However, some N. glabratus isolates were resistant to miconazole, clotrimazole, and amphotericin B, while all P. kudriavzevii isolates resisted clotrimazole. Overexpression of the CDR1 gene was noted in N. glabratus (CR, 21.53 ± 1.26; CLR, 84.96 ± 0.67), and the ERG11 and CDR1 genes in P. kudriavzevii ( ERG11 for CR, 28.56 ± 2.16; CDR1 for CLR, 35.89 ± 0.35). These results indicate that even in cases where an isolate is classified as susceptible by drug susceptibility testing, elevated gene expression may persist, and treatment should not be discontinued.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Candidiasis, VulvovaginalAntifungal AgentsDrug Resistance, FungalFungal ProteinsCandidaFemaleHumansMicrobial Sensitivity TestsPichiaAzoles

Stichwörter der Autor:innen

Nakaseomyces glabratusPichia kudriavzeviigene expersionvulvovaginal candidiasis

Substanzen

Antifungal AgentsFungal ProteinsAzoles

Autor:innen und Institutionen

  • Parasitology and Medical Mycology Department, Faculty of Medicine, Babol University of Medical Sciences, Babol, Iran.
  • Infectious Diseases and Tropical Medicine Research Center, Health Research Institute, Babol University of Medical Sciences, Babol, Iran.
  • Student Research Committee, Babol University of Medical Sciences, Babol, Iran.
  • Obstetrics and Gynecology Department, Faculty of Medicine, Babol University of Medical Sciences, Babol, Iran.
  • Infertility and Reproductive Health Research Center, Health Research Institute, Rouhani Hospital, Babol University of Medical Sciences, Babol, Iran.

ORCID-Profile: Fatemeh Zahra Ranjbar Golafshani, Firoozeh Kermani, Soheila Abbaszadeh Godarzi, Saeid Mahdavi Omran

Förderung

  • This paper is supported by the financial grant associated with the M.Sc. dissertation of Fatemeh Zahra Ranjbar Golafshani at Babol University of Medical Scienc…

Zitieren

APA

Ranjbar Golafshani, F. Z., Kermani, F., Abbaszadeh Godarzi, S., & Mahdavi Omran, S. (2025). Non‐ albicans Candida in Vulvovaginal Candidiasis: Antifungal Resistance and Expression of ERG11 , CDR1 , CDR2 , and MDR1 Genes. MicrobiologyOpen, 14(6). https://doi.org/10.1002/mbo3.70123

Vancouver

Ranjbar Golafshani FZ, Kermani F, Abbaszadeh Godarzi S, Mahdavi Omran S. Non‐ albicans Candida in Vulvovaginal Candidiasis: Antifungal Resistance and Expression of ERG11 , CDR1 , CDR2 , and MDR1 Genes. MicrobiologyOpen. 2025;14(6). doi:10.1002/mbo3.70123

BibTeX
@article{RanjbarGolafshani2025,
  author = {Ranjbar Golafshani, Fatemeh Zahra and Kermani, Firoozeh and Abbaszadeh Godarzi, Soheila and Mahdavi Omran, Saeid},
  title = {Non‐ albicans Candida in Vulvovaginal Candidiasis: Antifungal Resistance and Expression of ERG11 , CDR1 , CDR2 , and MDR1 Genes},
  journal = {MicrobiologyOpen},
  year = {2025},
  volume = {14},
  number = {6},
  doi = {10.1002/mbo3.70123}
}
Kostenlos starten →